Foxo Technologies Inc
AMEX:FOXO
Net Margin
Foxo Technologies Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
F
|
Foxo Technologies Inc
AMEX:FOXO
|
2.3m USD |
-173%
|
|
| US |
|
Ezenia! Inc
OTC:EZEN
|
567B USD |
-130%
|
|
| DE |
|
SAP SE
XETRA:SAP
|
292.3B EUR |
16%
|
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
322B USD |
18%
|
|
| US |
|
Salesforce Inc
NYSE:CRM
|
250.1B USD |
16%
|
|
| US |
|
Intuit Inc
NASDAQ:INTU
|
212.4B USD |
19%
|
|
| US |
|
Adobe Inc
NASDAQ:ADBE
|
160.6B USD |
30%
|
|
| US |
N
|
NCR Corp
LSE:0K45
|
150.8B USD |
27%
|
|
| US |
|
Applovin Corp
NASDAQ:APP
|
109.9B USD |
37%
|
|
| US |
|
Microstrategy Inc
NASDAQ:MSTR
|
98.4B USD |
-1 163%
|
|
| US |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
80.7B USD |
22%
|
Foxo Technologies Inc
Glance View
FOXO Technologies, Inc. develops genetic sequencing technology artificial intelligence and bioinformatics tools. The company is headquartered in Minneapolis, Minnesota and currently employs 24 full-time employees. The company went IPO on 2020-12-11. The firm is focused on commercializing longevity science through products and services that serve the life insurance industry. Its epigenetic technology applies artificial intelligence (AI) to deoxyribonucleic acid (DNA) methylation to identify molecular biomarkers of human health and aging. The firm operates through two segments: FOXO Labs and FOXO Life. FOXO Labs is commercializing epigenetic biomarker technology to be used for mortality underwriting and risk classification in the global life insurance industry. Its biomarker technology enables the adoption of new saliva-based health and wellness biomarker solutions for underwriting and risk assessment. FOXO Life is redefining the relationship between consumers and insurers by combining life insurance with healthy longevity. FOXO Life seeks to transform the value proposition of the life insurance carrier from a provider of mortality risk protection products.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Foxo Technologies Inc's most recent financial statements, the company has Net Margin of -173.3%.
You don't have any saved screeners yet